Russian virosomal vaccine Efficacy and safety evaluation
Virosomal vaccines are new generation vaccines which activate humoral and cell-mediated immunity, induce stronger immunogenicity and sustain long-term protective immunity. The article tells about the results of clinical studies of the Russian next generation influenza vaccine Ultriks®, demoinstratin...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2015-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/162 |
| _version_ | 1797841438494425088 |
|---|---|
| author | T. A. Grenkova E. P. Selkova N. V. Gudova |
| author_facet | T. A. Grenkova E. P. Selkova N. V. Gudova |
| author_sort | T. A. Grenkova |
| collection | DOAJ |
| description | Virosomal vaccines are new generation vaccines which activate humoral and cell-mediated immunity, induce stronger immunogenicity and sustain long-term protective immunity. The article tells about the results of clinical studies of the Russian next generation influenza vaccine Ultriks®, demoinstrating its safety, high immunogenic activity against influenza viruses H1N1, H3N2 and B, as well as epidemiological effectiveness. |
| first_indexed | 2024-04-09T16:30:49Z |
| format | Article |
| id | doaj.art-7be2125e0bb4462c9900bab6c096efe1 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:30:49Z |
| publishDate | 2015-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-7be2125e0bb4462c9900bab6c096efe12023-04-23T06:57:07ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902015-12-01049610110.21518/2079-701X-2015-4-96-101162Russian virosomal vaccine Efficacy and safety evaluationT. A. Grenkova0E. P. Selkova1N. V. Gudova2the Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevskiy, Federal Service for Oversight of Consumer Protection and Welfarethe Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevskiy, Federal Service for Oversight of Consumer Protection and Welfarethe Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevskiy, Federal Service for Oversight of Consumer Protection and WelfareVirosomal vaccines are new generation vaccines which activate humoral and cell-mediated immunity, induce stronger immunogenicity and sustain long-term protective immunity. The article tells about the results of clinical studies of the Russian next generation influenza vaccine Ultriks®, demoinstrating its safety, high immunogenic activity against influenza viruses H1N1, H3N2 and B, as well as epidemiological effectiveness.https://www.med-sovet.pro/jour/article/view/162вакцинопрофилактикаиммунитетбезопасностьгриппиммуногенностьвакцинаультрикс®fluvaccine preventionimmunitysafetyimmunogenicityultriks® vaccine |
| spellingShingle | T. A. Grenkova E. P. Selkova N. V. Gudova Russian virosomal vaccine Efficacy and safety evaluation Медицинский совет вакцинопрофилактика иммунитет безопасность грипп иммуногенность вакцина ультрикс® flu vaccine prevention immunity safety immunogenicity ultriks® vaccine |
| title | Russian virosomal vaccine Efficacy and safety evaluation |
| title_full | Russian virosomal vaccine Efficacy and safety evaluation |
| title_fullStr | Russian virosomal vaccine Efficacy and safety evaluation |
| title_full_unstemmed | Russian virosomal vaccine Efficacy and safety evaluation |
| title_short | Russian virosomal vaccine Efficacy and safety evaluation |
| title_sort | russian virosomal vaccine efficacy and safety evaluation |
| topic | вакцинопрофилактика иммунитет безопасность грипп иммуногенность вакцина ультрикс® flu vaccine prevention immunity safety immunogenicity ultriks® vaccine |
| url | https://www.med-sovet.pro/jour/article/view/162 |
| work_keys_str_mv | AT tagrenkova russianvirosomalvaccineefficacyandsafetyevaluation AT epselkova russianvirosomalvaccineefficacyandsafetyevaluation AT nvgudova russianvirosomalvaccineefficacyandsafetyevaluation |